Annual incidence rate per 100 person-years trend for ART treatment outcomes. by Ekerette Emmanuel Udoh (7326194)

Subjects:

Weekly aerobic exercise volume over time for the DHA and placebo groups combined (n  by Claire M. Douglas (21238238)

Subjects:

Fourier Transform Infra-Red Spectroscopy (FT-IR) of Native Orientin and NF-Orientin. by Yashwanth Elumalai (21743452)

Subjects:

Illustrates photographs of the CAM were captured to visualize the vascular plexus following the control group, native-orientin (5 μM), native-orientin (10 μM), NF-O (5 μM), and NF-... by Yashwanth Elumalai (21743452)

Subjects:

A) KRAS-orientin docked complex illustrated in the 2-d interaction, B) 3-d interaction of KRAS-orientin, C) 2-d interaction between NTRK and orientin, and D) 3-d interaction patter... by Yashwanth Elumalai (21743452)

Subjects:

Weekly resistance training frequency over time for the DHA and placebo groups combined (n  by Claire M. Douglas (21238238)

Subjects:

Quality of life scores at baseline (week 0) and end of chemotherapy (week 18) in the DHA and placebo groups. by Claire M. Douglas (21238238)

Subjects:

Graphical representation of wound healing assay. by Yashwanth Elumalai (21743452)

Subjects:

MTT assay and Wound healing assay raw data. by Yashwanth Elumalai (21743452)

Subjects:

Aggregation and morphology of MCF-7 cell lines A) Control, B) Native-O 10µM, C) Native-O 25µM, D) Native-O 50µM, E) NF-O 10µM, F) NF-O 25µM and G) NF-O 50µM depicts the effects of... by Yashwanth Elumalai (21743452)

Subjects:

Participant demographic and clinical characteristics. by Claire M. Douglas (21238238)

Subjects:

Synthesis preparation of nano-formulated orientin by using solvent evaporation method. by Yashwanth Elumalai (21743452)

Subjects:

UV-Spectrophotometer of Native Orientin and NF-Orientin. by Yashwanth Elumalai (21743452)

Subjects:

Microscopic pictorial representation of wound healing assay (Control, native orientin (NF) and NF-O in 0 h and 24 h). by Yashwanth Elumalai (21743452)

Subjects:

Interaction profile of targeted receptor molecules and orientin. by Yashwanth Elumalai (21743452)

Subjects:

Quality of life scores at baseline (week 0) and the end of chemotherapy (week 18) in participants that met (≥ 150 minutes/week) or did not meet (< 150 minutes/week) WHO’s aerobic e... by Claire M. Douglas (21238238)

Subjects:

Flow of participants through the DHA WIN RCT. Abbreviations: Docosahexaenoic acid (DHA), Docosahexaenoic acid for Women with Breast Cancer in the Neoadjuvant Setting (DHA WIN), ran... by Claire M. Douglas (21238238)

Subjects:

Illustrates the schematic representation of <i>in ova</i> experimentation showing with timeline. by Yashwanth Elumalai (21743452)

Subjects:

Dose determination and cell viability estimation of (A) NF-Orientin and (B) Native Orientin using MCF-7 cell lines. by Yashwanth Elumalai (21743452)

Subjects:

Graphical representation on the impact of native orientin and NF-orientin on the expression of VEGF-A and FGF2 mRNA isolated from the CAM. by Yashwanth Elumalai (21743452)

Subjects: